Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019

Abstract

Objective To estimate the global burden of type 2 diabetes in adolescents and young adults (aged 15-39 years) from 1990 to 2019. Design Systematic analysis. Data source Global Burden of Disease Study 2019. Participants aged 15-39 years from 204 countries and territories, 1990-2019. Main outcomes measures Age standardised incidence rate, age standardised disability adjusted life years (DALY) rate, and age standardised mortality rate for type 2 diabetes in people aged 15-39 years from 1990 to 2019, and proportional DALY attributable to different risk factors. Results From 1990 to 2019, significant increases in age standardised incidence rate and age standardised DALY rate were found for type 2 diabetes in adolescents and young adults globally (P<0.001). Age standardised incidence rate (per 100 000 population) increased from 117.22 (95% confidence interval 117.07 to 117.36) in 1990 to 183.36 (183.21 to 183.51) in 2019, and age standardised DALY rate (per 100 000 population) increased from 106.34 (106.20 to 106.48) in 1990 to 149.61 (149.47 to 149.75) in 2019. The age standardised mortality rate (per 100 000 population) was modestly increased from 0.74 (0.72 to 0.75) in 1990 to 0.77 (0.76 to 0.78) in 2019. When grouped by countries with different sociodemographic indexes, countries with a low-middle and middle sociodemographic index had the highest age standardised incidence rate and age standardised DALY rate in 2019, whereas countries with a low sociodemographic index had the lowest age standardised incidence rate but the highest age standardised mortality rate. Women generally had higher mortality and DALY rates than men at ages <30 years, but differences between the sexes were reversed in those aged >30 years except in countries with a low sociodemographic index. The main attributable risk factor for DALY for early onset type 2 diabetes was high body mass index in all regions by sociodemographic index. The proportional contribution of other risk factors varied across regions, however, with higher proportions of ambient particulate air pollution and smoking in countries with a high sociodemographic index and higher proportions of household air pollution from solid fuels and diet low in fruit in countries with a low sociodemographic index. Conclusions Early onset type 2 diabetes is a growing global health problem in adolescents and young adults, especially in countries with a low-middle and middle sociodemographic index. A greater disease burden in women aged <30 years was found. Specific measures are needed in countries with different levels of socioeconomic development because of the variable attributable risk factors for type 2 diabetes in adolescents and young adults.

Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study

“…Instead, we investigated and adjusted for the presence of hypertension and dyslipidemia, which are representative comorbidities of T2DM. Our study included approximately half of those under the age of 40, and both T2DM and severe COVID-19 incidence in young people are known to increase linearly with body weight [ 22 , 23 ]. However, we were unable to retrieve the weight of the subjects from the database.…”

Learning to fake it: limited responses and fabricated references provided by ChatGPT for medical questions

“…The medical questions were identified by selecting five research articles published at the end of 2022 in four high-impact factor medical journals (BMJ (13)(14)(15)(16)(17), CMAJ (18)(19)(20)(21)(22), the Lancet (23)(24)(25)(26)(27)(28)(29)(30)(31)(32) and NEJM). These 20 articles spanned different topics and fields.…”

GLP-1R Signaling and Functional Molecules in Incretin Therapy

“…It is critical to implement incretin therapy before severe pancreatic β-cell mass destruction or dysfunction. Unfortunately, in recent decades, the population of adolescents and young adults with T2DM is increasing [ 159 ], which highlights the urgency of early diagnosis. Although conventional diabetes diagnostic indicators such as fasting plasma glucose and HbA1c are simple and practicable, they do not provide the specificity to distinguish pathways related to pancreatic β-cell mass destruction or dysfunction [ 160 , 161 ].…”